U.S. Markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
31.08+0.05 (+0.16%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue17,33161120
Cost of Revenue4,4062,500-
Gross Profit12,925-2,439120
Operating Expenses
Research Development99,28473,86960,602
Selling General and Administrative186,45688,30432,748
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-272,815-164,612-93,230
Income from Continuing Operations
Total Other Income/Expenses Net2,763499755
Earnings Before Interest and Taxes-270,052-164,113-92,475
Interest Expense---
Income Before Tax-270,052-164,113-92,475
Income Tax Expense1,341330-
Minority Interest---
Net Income From Continuing Ops-271,393-164,443-92,475
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-271,393-164,443-92,475
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-271,393-164,443-92,475